311 related articles for article (PubMed ID: 14975390)
1. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
2. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
4. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
5. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
6. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
8. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
[TBL] [Abstract][Full Text] [Related]
9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
10. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
11. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.
Carter RF; Valli VE; Lumsden JH
Can J Vet Res; 1986 Apr; 50(2):154-64. PubMed ID: 3756669
[TBL] [Abstract][Full Text] [Related]
12. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.
Teske E; Wisman P; Moore PF; van Heerde P
Exp Hematol; 1994 Nov; 22(12):1179-87. PubMed ID: 7925781
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
18. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases.
Fournel-Fleury C; Ponce F; Felman P; Blavier A; Bonnefont C; Chabanne L; Marchal T; Cadore JL; Goy-Thollot I; Ledieu D; Ghernati I; Magnol JP
Vet Pathol; 2002 Jan; 39(1):92-109. PubMed ID: 12102223
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
20. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.
Sözmen M; Tasca S; Carli E; De Lorenzi D; Furlanello T; Caldin M
J Vet Diagn Invest; 2005 Jul; 17(4):323-30. PubMed ID: 16130989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]